HBW Insight is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By



This article was originally published in The Rose Sheet

Executive Summary

Christian Dior Higher and Kenzo Flower fueled Perfumes & Cosmetics sales for the year, but division operating income dropped 19% to $130.4 mil. (€1=$.88) largely due to a slowdown in the economy, luxury goods retailer says in 1March 7 release. Selective Retailing division, which includes Sephora and Duty Free Sales, recorded operating loss of $169.8 mil. from loss of $1.8 mil. in 2000. Loss in Selective Retailing contributed to lower consolidated earnings, LVMH says. Group generated net income of $8.8 mil. in 2001 compared to $639.9 mil. the prior year, remaining in the black due to a $756.2 mil. gain related to the sale of its Gucci shares...

You may also be interested in...

Sephora Aiming For Profitability By 2003 – LVMH

LVMH is working to achieve a "pronounced improvement" in profitability in its Selective Distribution division this year, Financial Communications Director Christopher Hollis said during the luxury goods manufacturer's first quarter sales presentation April 24

Verona Details COPD Opportunity For Ensifentrine

Verona Pharma’s candidate COPD therapy ensifentrine has a first-in-class dual mechanism of action and is to be explored as an add-on to LAMA and LABA therapy in two Phase III clinical studies.

Warning Letter Roundup & Recap – 2 June 2020

No device-related warning letters were released by the US FDA the week of 2 June.




Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts